2002
DOI: 10.1016/s0738-081x(02)00266-3
|View full text |Cite
|
Sign up to set email alerts
|

Photodynamic therapy: unapproved uses, dosages, or indications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
42
0
5

Year Published

2004
2004
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(47 citation statements)
references
References 105 publications
0
42
0
5
Order By: Relevance
“…The X-band EPR spectra were recorded in situ using a field-modulated CW Towers, 1991), as well as for naturally occurring quinones (Alegría et al, 1999;Inbaraj et al, 1999) and other substances (Arnason et al, 1992;Wu et al, 2000). The photoproduced oxygen reactive species ( · OH, O 2 · − , 1 O 2 ) play a specific and important role in cell damage in photodynamic therapy (Henderson and Dougherty, 1992;Salva, 2002;Vrouenraets et al, 2003;Dolmans et al, 2003). On the other hand, the medical application of photoactive therapeutic compounds could bring undesired side-reactions in treated patients (Filipe et al, 1997;Krutmann, 2000), or technical problems during drug applications (Dodds et al, 1997;Dodds et al, 1998;Li et al, 2001).…”
Section: Methodsmentioning
confidence: 99%
“…The X-band EPR spectra were recorded in situ using a field-modulated CW Towers, 1991), as well as for naturally occurring quinones (Alegría et al, 1999;Inbaraj et al, 1999) and other substances (Arnason et al, 1992;Wu et al, 2000). The photoproduced oxygen reactive species ( · OH, O 2 · − , 1 O 2 ) play a specific and important role in cell damage in photodynamic therapy (Henderson and Dougherty, 1992;Salva, 2002;Vrouenraets et al, 2003;Dolmans et al, 2003). On the other hand, the medical application of photoactive therapeutic compounds could bring undesired side-reactions in treated patients (Filipe et al, 1997;Krutmann, 2000), or technical problems during drug applications (Dodds et al, 1997;Dodds et al, 1998;Li et al, 2001).…”
Section: Methodsmentioning
confidence: 99%
“…The light source for PAD can be divided into three main categories namely: (1) broad spectrum lamps, (2) Light emitting diode lamps (LED) and 3) lasers. 80 Among the different sources, lasers show some advantages like monochromacy which allows the laser to best interact with PS due to matching precisely with its peak absorption, which reduces unnecessary tissue heating by bandwidths not effective in PDT reaction. 81 In dentistry, most of the PS are activated by the red light wave lengths between 630-700 nm.…”
Section: Lightmentioning
confidence: 99%
“…First, it is possible to use a single molecule for both purposes, since most porphyrin-like compounds can both emit fluorescence *Address correspondence to this author at the Ontario Cancer Institute/University of Toronto, MaRS Center, 101 College Street, Toronto, ON M5G 1L7, Canada; Tel: +1-416-581-7666; Fax: +1-416-581-7667; E-mail: gang.zheng@uhnres.utoronto.ca (for NIRF-I) and produce cytotoxic reactive oxygen species (for PDT) when activated by light [5,6]. Second, the concentrations required for killing and imaging cells are in the same range and third, both of the techniques are promising in vivo cancer imaging and treatment modalities [7,8].…”
Section: Combined Cancer Imaging and Therapymentioning
confidence: 99%